Shenzhen - Delayed Quote CNY

Apeloa Pharmaceutical Co.,Ltd (000739.SZ)

13.97
+0.02
+(0.14%)
As of 10:27:12 AM GMT+8. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Fangmeng Zhu Chairman -- -- 1972
Mr. Chun He General Manager -- -- 1974
Mr. Xinliang Xu Vice Chairman -- -- 1969
Mr. Jinhui Zhang Chief Financial Officer -- -- 1975
Mr. Min Jin Senior Deputy GM & GM of API Division -- -- 1968
Mr. Lei Cai Deputy GM & GM of CDMO Division -- -- 1979
Mr. Yuwang Zhou Deputy GM & Secretary -- -- 1966
Mr. Hui Zhang Chief Technology Officer -- -- --

Apeloa Pharmaceutical Co.,Ltd

No. 99 South Hengdian Road
Hengdian Town
Dongyang, 322118
China
86 579 8655 7494 https://www.apeloa.com
Sector: 
Healthcare
Full Time Employees: 
7,060

Description

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People's Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.

Corporate Governance

Apeloa Pharmaceutical Co.,Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 23, 2024 at 12:00 AM UTC

Ex-Dividend Date